Leos-Gallego CA

Language: Spanish
References: 14
Page: 149-152
PDF size: 117.50 Kb.

ABSTRACT

Objective: To determine the usefulness of transurethral resection of the prostate (TURP) in diagnosing prostate cancer.
Materials and methods: In the ISSSTE General Hospital in Hermosillo, Sonora, 52 case records of patients having undergone diagnostic TURP from March 1998 to March 2007 were reviewed. All patients undergoing TURP had presented with persistently elevated prostate specific antigen (PSA) and two negative biopsy series.
Results: From a total of 52 patients, the pathology studies reported 14 cases (27%) of prostate cancer and the remaining cases were of benign prostatic hyperplasia (BPH) and prostatitis.
Conclusions: Early prostate cancer detection has allowed surgical procedures such as radical prostatectomy to be carried out, offering the patient hope for treatment. Diagnostic TURP in patients presenting with elevated PSA and various negative biopsy series can be of great value in confirming the presence of cancer so that radical prostatectomy can be performed, resulting in treatment possibilities.
In our series the presence of cancer was confirmed in 27% of a total of 52 patients. Other series have shown confirmation in 4%, 30% and even 50% of patients studied. Therefore we consider TURP to be an alternative that should be taken into consideration under these circumstances until other more precise prostate cancer detection methods become available.

REFERENCES

1. Metlin C Gronberg Henrik. Prostate cancer epidemiology. Lancet 2003;361:859-64.

2. Murphy G, Ho R, Memck H. The national cancer data base report on longitudinal observations on prostate cancer. Cancer 1996;7:2162-6.

3. Brat O. The difficult case in prostate cancer diagnosis when is a diagnostic TURP indicated? Eur Urol 2006;49:769-71.

4. McNeal JE. Origin and evolution of benign prostatic enlargement. Invest Urol 1978;15:340.

5. Steuber T, Karakiewicz PI, Augustin H et al. Transition zone cancers undermine the predictive accuracy of partin table stage predictions. J Urol 2005;173: 737-41.

6. Irai J, Millet C, Levillain P, Begon F. Serum to urinary prostate specific antigen ratio : It`s impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 ng/mL. J Urol 1997;157: 185-88.

7. Puppo P, Introini C, Calvi P, Naselli A. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session softer repeated negative biopsies in the diagnosis of prostate cancer. Eur Urol 2006;49:873-8.

8. Kitamura H, Masumori N, Tanuma Y et al. Does transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systemic sextant and transition zone biopsies? Int J Urol 2002;9:95-9.

9. Chen ME, Troncoso P, Tang K, Babaian RJ, Johnston D. Compararison of prostate biopsy scenes by computer simulation. Urology 1999;53:951-60.

10. Chappell B, McLoughlin J. Technical considerations when obtaining and interpreting prostatic biopsies from men with suspicion of early prostate cancer: part I & II. BJU Int 2005;95:1135-45.

11. Neyra Argote, Ramos Solano, Álvarez Nuño. Cáncer de próstata de difícil localización, metodología diagnóstica. Rev Mex Urol 2000;60:221-4.

12. Pelzer AE, Bektic J, Berger AP et al. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project. Eur Urol 2005;48:916-21.

13. Philip J, Dutta Roy S, Scally J, Foster CS, Javle P. Importance of TURP in diagnosing prostate cancer in men with multiple negative biopsies. Prostate 2005;64:200-2.

14. Pryor MB, Schellhammer PF. The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasoundguided prostate biopsies. Clin Prostate Cancer 2002; 1:172-6.